Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Dividends payables (2016 - 2020)

Medifast (MED) has disclosed Dividends payables for 6 consecutive years, with $13.8 million as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Dividends payables rose 0.82% year-over-year to $13.8 million, compared with a TTM value of $13.8 million through Dec 2020, up 0.82%, and an annual FY2020 reading of $13.8 million, up 0.82% over the prior year.
  • Dividends payables was $13.8 million for Q4 2020 at Medifast, up from $13.7 million in the prior quarter.
  • Across five years, Dividends payables topped out at $13.8 million in Q4 2020 and bottomed at $4.0 million in Q4 2016.
  • Average Dividends payables over 5 years is $9.4 million, with a median of $9.1 million recorded in 2018.
  • The sharpest move saw Dividends payables skyrocketed 51.15% in 2017, then grew 0.82% in 2020.
  • Year by year, Dividends payables stood at $4.0 million in 2016, then soared by 51.15% to $6.1 million in 2017, then soared by 49.66% to $9.1 million in 2018, then soared by 50.15% to $13.7 million in 2019, then increased by 0.82% to $13.8 million in 2020.
  • Business Quant data shows Dividends payables for MED at $13.8 million in Q4 2020, $13.7 million in Q4 2019, and $9.1 million in Q4 2018.